Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Cancer Ratio and Cancer Ratio Plus in the Differentiation Between Malignant and Tuberculous Pleural Effusions .

NCT07766876 is registered in ClinicalTrials.gov with Sohag University as lead sponsor.

NCT NCT07766876
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07766876 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Cancer Ratio and Cancer Ratio Plus in the Differentiation Between Malignant and Tuberculous Pleural Effusions .
Lead sponsor
Sohag University
Phase
Observational
Overall status
Not yet recruiting
Start date
September 1, 2026
Completion date
August 31, 2027
Enrollment
120 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

malignant pleural effusion, tuberculous pleural effusion